Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott Medical Devices
This is a prospective, open-label, and multi-centered feasibility registry (single arm study). Approximately 36 subjects with prohibitive risk degenerative mitral regurgitation (DMR) who receive at least 1 commercial MitraClip will be registered at up to 10 US sites.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject must consent to receiving the MitraClip device
Subject must consent, be able, and commit to wearing the Actiwatch continuously for approximately 7 months
Subject must consent to use of their data from this registry for purposes of exploratory research and publication and presentation
You may not be if
Subject is not a member of vulnerable population
Subject must not have any disabilities that preclude reliable data collection from the Actiwatch, e.g., epilepsy with uncontrolled recurring episodes, serious stage degenerative/disabling disease (e.g. Parkinson's disease), inability to walk or will require walking aids, etc.
Clareo Health | A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device
